Form 4 for MIRA MIRA PHARMACEUTICALS, INC.
Accepted 2025-09-03 00:00:00 ET · period of report 2025-08-29 · accession 0001641172-25-026388 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-03 | 2025-08-29 | MIRA | Aminov Erez | CEO, Dir | A - Grant | $1.37 | +62.5K | 844.7K | +8% | +$85.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-29 | A | A | 62,500 | $1.37 | 844,700 | D | — | — | (F1) Represents 62,500 RSUs vesting immediately, granted and issued to the Reporting Person from the Issuer's 2022 Omnibus Incentive Plan in connection with the Reporting Person's achievement of certain milestones pursuant to the Reporting Person's Executive Incentive Compensation Plan. |